Published in Cancer Biol Ther on January 28, 2010
γ-Tubulin complexes in microtubule nucleation and beyond. Mol Biol Cell (2015) 0.86
Microtubule-severing ATPase spastin in glioblastoma: increased expression in human glioblastoma cell lines and inverse roles in cell motility and proliferation. J Neuropathol Exp Neurol (2011) 0.81
Kinesin-14 and kinesin-5 antagonistically regulate microtubule nucleation by γ-TuRC in yeast and human cells. Nat Commun (2014) 0.81
Increased α-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma. Dig Dis Sci (2013) 0.80
Characterization of Adenomatous Polyposis Coli Protein Dynamics and Localization at the Centrosome. Cancers (Basel) (2016) 0.77
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
Microtubules as a target for anticancer drugs. Nat Rev Cancer (2004) 13.93
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature (2008) 5.98
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet (2007) 4.69
Centrosome-independent mitotic spindle formation in vertebrates. Curr Biol (2000) 4.50
Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer (2007) 4.16
Microtubule-dependent microtubule nucleation based on recruitment of gamma-tubulin in higher plants. Nat Cell Biol (2005) 3.94
Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol (2007) 3.93
Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci U S A (2002) 3.81
Requirement of a centrosomal activity for cell cycle progression through G1 into S phase. Science (2001) 3.56
Microtubule-organizing centres: a re-evaluation. Nat Rev Mol Cell Biol (2007) 3.28
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol (1992) 3.15
Microtubule minus-end anchorage at centrosomal and non-centrosomal sites: the role of ninein. J Cell Sci (2000) 3.07
Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis (2008) 2.86
Microtubule nucleation: gamma-tubulin and beyond. J Cell Sci (2006) 2.71
Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res (2003) 2.68
gamma-Tubulin in mammalian cells: the centrosomal and the cytosolic forms. J Cell Sci (1996) 2.59
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res (2006) 2.58
Generation of noncentrosomal microtubule arrays. J Cell Sci (2006) 2.51
Centrosome amplification and the development of cancer. Oncogene (2002) 2.51
Microtubule nucleation and anchoring at the centrosome are independent processes linked by ninein function. J Cell Sci (2005) 2.44
The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett (2005) 2.25
The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature (2000) 2.17
Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat (1994) 2.05
Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res (2001) 2.01
Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents. Ann Oncol (2007) 1.90
Centrosomal and non-centrosomal microtubules. Biol Cell (1999) 1.64
Amplified centrosomes in breast cancer: a potential indicator of tumor aggressiveness. Breast Cancer Res Treat (2002) 1.58
Centrosomes and cancer: how cancer cells divide with too many centrosomes. Cancer Metastasis Rev (2009) 1.52
Microtubule release from the centrosome in migrating cells. J Cell Biol (2002) 1.44
Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Mol Cell Biol (2005) 1.33
The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett (2006) 1.32
Roles of BRCA1 in centrosome duplication. Oncogene (2002) 1.29
BRCA1 regulates gamma-tubulin binding to centrosomes. Cancer Biol Ther (2007) 1.15
Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat (2006) 1.12
Self-organization of an acentrosomal microtubule network at the basal cortex of polarized epithelial cells. J Cell Biol (2005) 1.10
Centrosome amplification and the origin of chromosomal instability in breast cancer. J Mammary Gland Biol Neoplasia (2004) 1.08
Chromatin remodeling proteins interact with pericentrin to regulate centrosome integrity. Mol Biol Cell (2007) 1.07
The Syk tyrosine kinase localizes to the centrosomes and negatively affects mitotic progression. Cancer Res (2005) 1.05
Centrosome function in normal and tumor cells. J Cell Biochem (2006) 1.01
Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer (2003) 0.99
Regulation of microtubule nucleation from membranes by complexes of membrane-bound gamma-tubulin with Fyn kinase and phosphoinositide 3-kinase. Biochem J (2008) 0.99
Gamma-tubulin at ten: progress and prospects. Cell Struct Funct (1999) 0.99
BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells. Int J Cancer (2009) 0.98
A monoclonal antibody, raised against mammalian centrosomes and screened by recognition of plant microtubule organizing centers, identifies a pericentriolar component in different cell types. J Cell Sci (1992) 0.96
The BRCA1 E3 ubiquitin ligase controls centrosome dynamics. Cell Cycle (2006) 0.90
Microtubule-dependent microtubule nucleation in plant cells. J Plant Res (2006) 0.89
Syk: a new player in the field of breast cancer. Breast Cancer Res (2000) 0.88
Microtubule nucleating capacity of centrosomes in tissue sections. J Histochem Cytochem (1999) 0.83
Intensity-based signal separation algorithm for accurate quantification of clustered centrosomes in tissue sections. Microsc Res Tech (2006) 0.82
Increased gamma-tubulin expression and P16INK4A promoter methylation occur together in preinvasive lesions and carcinomas of the breast. Ann Oncol (2009) 0.80
Physical confinement alters tumor cell adhesion and migration phenotypes. FASEB J (2012) 1.74
Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells. Cancer Res (2008) 1.37
Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement. Cancer Res (2010) 1.29
Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res (2009) 1.29
Chemotaxis of cell populations through confined spaces at single-cell resolution. PLoS One (2012) 1.22
Circulating giant macrophages as a potential biomarker of solid tumors. Proc Natl Acad Sci U S A (2014) 1.18
Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment. Exp Cell Res (2007) 1.17
Antimitotic chemotherapeutics promote adhesive responses in detached and circulating tumor cells. Breast Cancer Res Treat (2009) 1.14
Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test. Cytometry A (2014) 1.02
Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells. Cancer Res (2010) 1.01
Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells. Mol Cancer Res (2004) 0.99
Formin-1 protein associates with microtubules through a peptide domain encoded by exon-2. Exp Cell Res (2006) 0.99
Mucin 16 is a functional selectin ligand on pancreatic cancer cells. FASEB J (2011) 0.96
Characterization of an HIV-targeted transcriptional gene-silencing RNA in primary cells. Hum Gene Ther (2012) 0.93
Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res (2013) 0.93
Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis. Proc Natl Acad Sci U S A (2013) 0.92
Effect of magnetic fields on tumor growth and viability. Comp Med (2011) 0.91
The effect of aerial parts of Echinacea on the circulating white cell levels and selected immune functions of the aging male Sprague-Dawley rat. Int Immunopharmacol (2003) 0.90
Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumors. Cancer Res (2013) 0.89
Biophysics of selectin-ligand interactions in inflammation and cancer. Phys Biol (2011) 0.88
Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis. PLoS One (2012) 0.88
Rapid detection of an ABT-737-sensitive primed for death state in cells using microplate-based respirometry. PLoS One (2012) 0.83
Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition. Breast Cancer Res (2013) 0.83
Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells. Breast Cancer Res Treat (2010) 0.83
Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells. Breast Cancer Res Treat (2010) 0.83
Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSK. J Biol Chem (2014) 0.83
Abba promotes PDGF-mediated membrane ruffling through activation of the small GTPase Rac1. Biochem Biophys Res Commun (2010) 0.80
Analysis of microtubule growth dynamics arising from altered actin network structure and contractility in breast tumor cells. Phys Biol (2017) 0.75
Partial thermal imidization of polyelectrolyte multilayer cell tethering surfaces (TetherChip) enables efficient cell capture and microtentacle fixation for circulating tumor cell analysis. Lab Chip (2020) 0.75